HUTCHMED DRC
Price & Volume
Stats
See more52W Range | $10.05-$19.50 |
Market Cap | $1.7B |
Shares Short | 209,783 |
Financials
See moreRevenue (12 Mos) | $548.5M |
Revenue Growth (YoY) | -16.5% |
Gross Profit (12 Mos) | $63.8M |
Diluted EPS | $2.65 |
News
See moreYahoo Finance • 8 days ago
HUTCHMED Highlights Sovleplenib ESLIM-02 Phase III Data in Warm Antibody Autoimmune Hemolytic Anemia Presented at EHA 2026 Congress
Yahoo Finance • 17 days ago
Why HUTCHMED (China) Limited (HCM) Is Gaining Attention After China Biotech Re-Rating
Yahoo Finance • 29 days ago
Hutchmed And Innovent Secure NMPA Approval For ELUNATE-TYVYT Combo In Advanced Renal Cell Carcinoma
About
CEO | Mr. Chig Fung Cheng BEc, CA |
CFO | Mr. Chig Fung Cheng BEc, CA |
Address | Cheung Kong Center, Hong Kong, Hong Kong |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 1,796 |